[ Price : $8.95]
Xenon Pharmaceuticals says its experimental epilepsy drug azetukalner met the primary endpoint in a late-stage clinical trial in p...[ Price : $8.95]
Ipsen voluntarily withdraws Tazverik (tazemetostat) from the market based on emerging data from the ongoing Phase 1b/3 SYMPHONY-1 ...[ Price : $8.95]
FDA investigators cite manufacturing and documentation issues at an Indian sterile drug facility operated by Maiva Pharma Private ...[ Price : $8.95]
A new national survey sees Americans expressing significantly greater confidence in FDA career scientists than in the leaders who ...[ Price : $8.95]
HHS says CBER director Vinay Prasad will step down at the end of April.[ Price : $8.95]
An FDA official discussing an ongoing dispute with UniQure raises concerns with outside experts who sit on agency advisory committ...[ Price : $8.95]
FDA says an expanded recall by Medline Industries involving certain reprocessed electrophysiology and ultrasound catheters has bee...[ Price : $8.95]
FDA issues a draft guidance outlining how drug manufacturers should respond to inspection findings documented in an FDA Form 483, ...